ArticleRadiology case reports2026
Secondary polycythemia as a rare cause of ischemic stroke: A case report.
Article in Radiology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Polycythemia is a known but underrecognized risk factor for ischemic stroke, particularly in the setting of chronic hypoxia. We report a rare case of pontine infarction associated with secondary polycythemia in a patient with chronic respiratory failure. A 52-year-old middle-aged man with a history of hypertension, combined pulmonary fibrosis and emphysema syndrome, receiving long-term oxygen therapy as well as bronchodilator treatment, presented with sudden-onset left-sided hemiparesis. Neurological examination confirmed a pyramidal syndrome. Brain MRI revealed an acute infarct in the left pons. Laboratory findings showed a hematocrit of 62.5% and elevated hemoglobin (20.1 g/dL). Work-up excluded primary polycythemia and revealed an elevated erythropoietin level (78.2 mIU/mL), consistent with a secondary hypoxia-induced cause. Oxygen saturation on room air was 88%. No atherosclerotic or cardioembolic sources were found. The patient underwent 6 therapeutic phlebotomy sessions over 3 weeks, which reduced hematocrit to 48.7%. Neurological symptoms improved within 4 days, with a modified Rankin Score improving from 3 to 1 at discharge. This case highlights the importance of considering secondary polycythemia in patients presenting with cryptogenic stroke and underlying chronic hypoxia. Early diagnosis and targeted interventions, including phlebotomy and antiplatelet therapy, can prevent recurrence and improve outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.